Clinical trial
Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis
NCT00071214 · Nabi Biopharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00071214 |
|---|---|
| Title | Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis |
| Official title | A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate Efficacy of StaphVAX, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine in Adults on Hemodialysis |
| Lead sponsor | Nabi Biopharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Staphylococcal Infections, Kidney Failure, Chronic |
| Intervention type | Biological |
| Interventions | S. aureus Type 5 and 8 Capsular Polysaccharide Conjugate Vaccine |
| Enrollment | 3,600 |
| Start date | Sep 1, 2003 |
| Completion | Sep 1, 2005 |
| First posted | Oct 17, 2003 |
| Last update posted | Jul 11, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: